FDA Denies Marketing to 6 Vuse Alto Flavored E Cigarette Products HCPLive Vaping Illness Tracker: 2,506 Cases and 54 Deaths The New York Times A Closer Look at Vaping Associated Lung Injury: What You Can Do for Your Patients Vaping Related Illness and Lung Disease NEJM Cases of Vaping Related Lung Illness Surge, Health Officials Say The New York Times NEW: After an extensive scientific review, FDA has authorized marketing of six Vuse Alto tobacco flavored e cigarette pods and accompanying power unit. Pods are sealed, pre filled, and non refillable. https: www.fda.gov tobacco products ctp newsroom